altretamine has been researched along with melphalan in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (76.19) | 18.7374 |
| 1990's | 3 (7.14) | 18.2507 |
| 2000's | 4 (9.52) | 29.6817 |
| 2010's | 3 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anderson, T; Bender, RA; Canellos, GP; Chabner, BA; DeVita, VT; Fisher, RI; Hubbard, SP; Simon, RM; Young, RC | 1 |
| Neijt, JP; Pinedo, HM; Roozendaal, KJ; Struyvenberg, A; van Lindert, AC; Vendrik, CP | 1 |
| Costa, J; Garvin, AJ; Ozols, RF; Simon, RM; Young, RC | 1 |
| Fisher, RI; Young, RC | 1 |
| Rutledge, F; Smith, JP; Stanhope, CR | 1 |
| Fraumeni, JF; Hoover, R; Reimer, RR; Young, RC | 1 |
| Bruntsch, U; Gallmeier, WM | 1 |
| Blessing, J; Lewis, GC | 1 |
| Barber, HR; Buterman, I; Kakarla, R; Kwon, T | 1 |
| Rutledge, FN; Smith, JP | 2 |
| Canellos, GP; Chabner, BA; DeVita, VT; Hubbard, SP; Young, RC | 1 |
| Venesmaa, P; Ylikorkala, O | 1 |
| Brady, MF; Buchsbaum, HJ; Homesley, HD; Major, FJ; Omura, GA; Park, RC; Yordan, E | 1 |
| Herbst, AL; Podczaski, E; Richman, CM; Weiser, PA | 1 |
| Brown, LB; Carmichael, JA; Fraser, RC; Kirk, ME; Krepart, GV; Levitt, M; Pater, JL; Roy, M; Shelley, WE; Wilson, KS | 1 |
| Brunner, KW; Dreher, E; Engeler, V; Forni, M; Goldhirsch, A; Greiner, R; Jungi, FW; Krauer, F; Sessa, C; Veraguth, P | 1 |
| Carmichael, JA; Ross, WM; Shelley, WE | 1 |
| Delgado, G; McLaughlin, EK; Smith, FP; Tuholski, N | 1 |
| Brunner, KW; Davis, BW; Dreher, E; Goldhirsch, A; Greiner, R; Joss, R; Locher, G; Reinhard, JP | 1 |
| Durie, BG; Salmon, SE | 1 |
| Courtenay, VD; Mills, J; Steel, GG | 1 |
| Honetz, N | 1 |
| Bross, DS; Ettinger, DS; Hernandez, E; Klein, JL; Leichner, PK; Order, SE; Pino y Torres, JL; Rosenshein, N | 1 |
| Brunner, KW; Burki, K; Davis, BW; Dreher, E; Goldhirsch, A; Greiner, R; Locher, GW | 1 |
| Blessing, JA; Buchsbaum, HJ; Homesley, HD; Leone, L; Miller, A; Morrow, CP; Omura, GA | 1 |
| Copeland, LJ; Edwards, CL; Gershenson, DM; Herson, J; Wharton, JT | 1 |
| Dreher, E; Goldhirsch, A; Greiner, R; Herrmann, U; Locher, G | 1 |
| Maggino, T; Onnis, A | 1 |
| Klein-Angerer, S; Kohorn, EI | 1 |
| Dembo, AJ | 1 |
| Ozols, RF; Young, RC | 1 |
| Davis, TE; Gilchrist, KW; Neville, AJ | 1 |
| Kessinger, A; Tempero, MA | 1 |
| Carbone, P; Vogl, S; Wadler, S; Yeap, B | 1 |
| Antipenkova, VI; Gershanovich, ML; Livshits, ME | 1 |
5 review(s) available for altretamine and melphalan
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The current status and future prospects of treatment for multiple myeloma.
Topics: Acute Kidney Injury; Altretamine; Anemia; Bacterial Infections; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Hypercalcemia; Interferons; Kidney Failure, Chronic; Melphalan; Meningeal Neoplasms; Multiple Myeloma; Spinal Cord Compression; Vinblastine; Vincristine; Vindesine | 1982 |
[Progress in the chemotherapy of ovarian cancer].
Topics: Adenocarcinoma, Mucinous; Altretamine; Antineoplastic Agents; Carcinoma, Squamous Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Melphalan; Neoplasm Staging; Ovarian Neoplasms; Prognosis | 1982 |
Radiotherapeutic management of ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leukemia; Melphalan; Ovarian Neoplasms | 1984 |
Chemotherapy of ovarian cancer.
Topics: Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Estrogen Antagonists; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Ovarian Neoplasms; Progestins; Tamoxifen | 1984 |
17 trial(s) available for altretamine and melphalan
| Article | Year |
|---|---|
Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Antineoplastic Agents; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Middle Aged; Ovarian Neoplasms; Prospective Studies | 1978 |
Hexa-CAF combination chemotherapy and other multiple-drug regimens in advanced ovarian carcinoma: present and future.
Topics: Altretamine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fluorouracil; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Triazines | 1979 |
Histologic grade in advanced ovarian cancer.
Topics: Altretamine; Cell Differentiation; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Ovarian Neoplasms; Prognosis | 1979 |
Advances in the staging and treatment of ovarian cancer.
Topics: Alkylating Agents; Altretamine; Antimetabolites, Antineoplastic; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Laparoscopy; Lymphatic Metastasis; Lymphography; Melphalan; Neoplasm Metastasis; Ovarian Neoplasms | 1977 |
Second trial drugs in ovarian cancer.
Topics: Altretamine; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Thiotepa | 1977 |
Ovarian cancer: use of multiple modality programs involving surgery, radiation therapy and chemotherapy.
Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Immunotherapy; Melphalan; Ovarian Neoplasms; Propionibacterium acnes; Radiotherapy Dosage | 1977 |
Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma.
Topics: Altretamine; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Maryland; Melphalan; Methotrexate; National Institutes of Health (U.S.); Ovarian Neoplasms; Prospective Studies; United States | 1975 |
Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary.
Topics: Adult; Altretamine; Antineoplastic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms | 1975 |
Subrenal capsule assay in selection of chemotherapy after operation for recurrent ovarian cancer.
Topics: Adult; Aged; Altretamine; Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Cystadenocarcinoma; Doxorubicin; Drug Screening Assays, Antitumor; Epirubicin; Female; Follow-Up Studies; Humans; Melphalan; Mice; Middle Aged; Ovarian Neoplasms; Subrenal Capsule Assay | 1991 |
Long-term follow-up and prognostic factor analysis in advanced ovarian carcinoma: the Gynecologic Oncology Group experience.
Topics: Adult; Aged; Altretamine; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Prognosis; Regression Analysis; Reoperation; Survival Rate | 1991 |
Second-line chemotherapy of stage III-IV ovarian carcinoma: a randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Doxorubicin; Female; Humans; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prognosis; Random Allocation; Statistics as Topic | 1987 |
Treatment of advanced ovarian cancer with surgery, chemotherapy, and consolidation of response by whole-abdominal radiotherapy.
Topics: Abdomen; Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Female; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Radiotherapy | 1988 |
Multimodality treatment of patients with advanced ovarian carcinoma.
Topics: Adenocarcinoma, Mucinous; Altretamine; Antibodies, Neoplasm; Carcinoma; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Melphalan; Ovarian Neoplasms; Ovary; Phosphorus Radioisotopes; Prospective Studies; Random Allocation | 1982 |
A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Altretamine; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Prognosis; Random Allocation; Triazines | 1983 |
A prospective randomized clinical trial of melphalan and cis-platinum versus hexamethylmelamine, adriamycin, and cyclophosphamide in advanced ovarian cancer.
Topics: Adult; Altretamine; Anemia; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Humans; Leukopenia; Melphalan; Middle Aged; Ovarian Neoplasms; Prospective Studies; Random Allocation; Thrombocytopenia | 1983 |
Radiotherapeutic management of ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Leukemia; Melphalan; Ovarian Neoplasms | 1984 |
Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Topics: Adult; Aged; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Cross-Over Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Survival Rate; Time Factors | 1996 |
21 other study(ies) available for altretamine and melphalan
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Acute leukemia after alkylating-agent therapy of ovarian cancer.
Topics: Acute Disease; Alkylating Agents; Altretamine; Chlorambucil; Cyclophosphamide; Female; Fluorouracil; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Melphalan; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Risk; Thiotepa; Time Factors; Uracil Mustard | 1977 |
[Chemotherapy of the ovarian carcinoma (author's transl)].
Topics: Altretamine; Antineoplastic Agents; Chlorambucil; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxyprogesterones; Mechlorethamine; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Nitrosourea Compounds; Ovarian Neoplasms; Thiotepa; Vinblastine; Vincristine | 1977 |
Current concepts in the management of ovarian cancer.
Topics: Adult; Aged; Altretamine; Castration; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; United States | 1978 |
Chemotherapy in advanced ovarian cancer.
Topics: Altretamine; Antineoplastic Agents; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms | 1975 |
Hexamethylmelamine, cyclophosphamide, adriamycin, cis-platinum chemotherapy as initial and second-line treatment of advanced ovarian carcinoma.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Reoperation | 1986 |
Advanced carcinoma of the ovary with central nervous system relapse.
Topics: Adenocarcinoma; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Melphalan; Meningeal Neoplasms; Middle Aged; Ovarian Neoplasms | 1988 |
Single agent vs. combination chemotherapy for ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Random Allocation; Time Factors | 1985 |
The treatment of ovarian cancer by a multimodality approach: remission induction with chemotherapy--hexa PAMP and PAMP regimens--followed by whole-abdominal radiation.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Prognosis | 1985 |
The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts.
Topics: Altretamine; Animals; Antineoplastic Agents; Cell Line; Cisplatin; Cyclophosphamide; Hindlimb; Humans; Melphalan; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Pancreatic Neoplasms; Semustine; Streptozocin; Transplantation, Heterologous; Vinblastine | 1982 |
Pathologic data of prognostic significance for remission induction in advanced ovarian carcinoma.
Topics: Adenocarcinoma; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Female; Humans; Melphalan; Middle Aged; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Reoperation | 1984 |
[New therapeutic concept for advanced ovarian cancer (FIGO IIb+c, III, IV)].
Topics: Adult; Aged; Altretamine; Cisplatin; Female; Humans; Melphalan; Middle Aged; Neoplasm Staging; Ovarian Neoplasms | 1983 |
Repetitive debulking surgery as adjuvant to chemotherapy in advanced epithelial ovarian cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Melphalan; Ovarian Neoplasms; Prospective Studies; Reoperation | 1984 |
The effect of chemotherapy on lymphocyte subpopulations and cell-mediated cytotoxicity in patients with ovarian carcinoma.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Cyclophosphamide; Cytotoxicity Tests, Immunologic; Cytotoxicity, Immunologic; Doxorubicin; Female; Humans; Leukocyte Count; Lymphocytes; Melphalan; Ovarian Neoplasms; T-Lymphocytes; Time Factors | 1984 |
The chemotherapy of granulosa cell tumors of the ovary: experience of the Wisconsin Clinical Cancer Center.
Topics: Adult; Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Granulosa Cell Tumor; Humans; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Ovarian Neoplasms; Prednisone; Retrospective Studies; Vincristine | 1984 |
Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma.
Topics: Adenocarcinoma, Papillary; Aged; Altretamine; Drug Therapy, Combination; Female; Humans; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Triazines | 1982 |
[Combination chemotherapy with hexamethylamine (Hexalen, Altretamine, Hexastat) and sarcolysine in advanced ovarian carcinoma].
Topics: Adult; Aged; Altretamine; Antineoplastic Agents, Alkylating; Carcinoma; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Humans; Melphalan; Middle Aged; Ovarian Neoplasms; Retrospective Studies; Treatment Outcome | 2000 |